Researchers develop first-of-its-kind therapy to enhance heart repair after a heart attack

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind experimental therapy that has the potential to enhance heart repair following a heart attack, preventing the onset of heart failure.

Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. – Biotech Investments

Eckert & Ziegler SE / Key word(s): Dividend Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. 19-March-2024 / 19:46

March 20, 2024

U.S. Deaths Tied to Extreme Temps May Double, Triple by Mid-21st Century

Deaths related to extreme temperatures in the U.S. were projected to increase substantially by the mid-21st century, with Black and Hispanic adults projected to disproportionately

September 24, 2024

Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial

Exscientia has backed the CDK7 candidate as the company “believes GTAEXS617 has the potential to overcome significant safety and efficacy limitations of existing approved treatments”.

July 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.